Numinus Wellness Approved For Health Canada Program To Provide Psychedelic-Assisted Therapy For Depression

Numinus Wellness Inc. (Numinus), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, announced that Health Canada has approved Numinus' application to complete psychedelic-assisted therapy using psilocybin to treat an applicant with treatment-resistant depression. This is Numinus' first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada's Special Access Program (SAP), which was amended January 5th, 2022 to include access to psychedelic compounds on a case-by-case basis.

To be considered for the SAP program, an applicant . . .